Active substance
Econazole
- SFDA 7
- US FDA 7
- US price lines 3
- Safety 2
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| GYNO-CORYL 150 MG VAGINAL OVULES | 150 mg | Vaginal capsule, soft · Vaginal use | 3 Blister | SAR 18.20 | Generic · Prescription | HAYAT PHARMACEUTICAL INDUSTRIES | Valid |
| DERMA-CORYL 1% CREAM | 1 % | Cream · Topical | 1 Tube | SAR 11.00 | Generic · Prescription | HAYAT PHARMACEUTICAL INDUSTRIES | Withdrawn by MAH · Not Marketed |
| GYNO-CORYL VAGINAL CREAM | 50 mg | Vaginal cream · Vaginal use | 1 Tube | SAR 17.25 | Generic · Prescription | HAYAT PHARMACEUTICAL INDUSTRIES | Withdrawn by MAH · Not Marketed |
| GYNO-PEVARYL-150 VAG. SUPPS 150MG | 150 mg | Vaginal capsule, soft · Vaginal use | 3 Blister | SAR 18.20 | NCE · Prescription | Janssen-Cilag International NV | Withdrawn by MAH · Not Marketed |
| GYNO-PEVARYL-50 VAG SUPPS 50MG | 50 mg | Vaginal capsule, soft · Vaginal use | 15 Blister | SAR 41.55 | NCE · Prescription | Janssen-Cilag International NV | Withdrawn by MAH · Not Marketed |
| PEVARYL CREAM 1% | 1 % | Cream · Topical | 1 Tube | SAR 19.40 | NCE · Prescription | SPIMACO ADDWAEIH | Withdrawn by MAH · Not Marketed |
| PEVARYL SPRAY POWDER 1% | 1 % | Cutaneous powder · Topical | 1 Tube | SAR 26.75 | NCE · Prescription | Janssen-Cilag International NV | Withdrawn by MAH · Not Marketed |
Indications — CHI Daman Drug Formulary
FUNGAL INFECTIONS OF THE GENITAL TRACT - CANDIDIASIS OF VULVA AND VAGINA; MATERNAL AND CHILD HEALTHCARE- VAGINAL CANDIDIASIS IN PREGNANCY
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| ECONAZOLE NITRATE | 1% | cream · topical | SUN PHARMA CANADA | Prescription | 26 Nov 2002 |
| ECONAZOLE NITRATE | 1% | cream · topical | PADAGIS ISRAEL | Prescription | 23 Jun 2004 |
| ECONAZOLE NITRATE | 1% | cream · topical | ENCUBE | Prescription | 17 Dec 2004 |
| ECOZA | 1% | aerosol, foam · topical | RESILIA PHARMS | Prescription | 24 Oct 2013 |
| ECONAZOLE NITRATE | 1% | cream · topical | AUROBINDO PHARMA USA | Prescription | 18 Apr 2018 |
| SPECTAZOLE | 1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | cream · topical | ALVOGEN | Discontinued | 23 Dec 1982 |
| ECONAZOLE NITRATE | 1% | cream · topical | CHARTWELL RX | Discontinued | 26 Nov 2002 |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | ECONAZOLE NITRATE 1% CREAM | $0.35094 | per GM | 23 Sep 2026 |
| US NADAC | ECONAZOLE NITRATE 1% CREAM | $0.39726 | per GM | 23 Sep 2026 |
| US NADAC | ECONAZOLE NITRATE 1% CREAM | $0.21159 | per GM | 23 Sep 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Safety signals and safety-related labeling changes
- US FDA 18 Nov 2019 ECOZA — safety-related labeling change
Labeling sections changed: Adverse Reactions; Use in Specific Populations - US FDA 8 Jun 2018 SPECTAZOLE — safety-related labeling change
Labeling sections changed: Drug Interactions; Use in Specific Populations
Combinations containing Econazole
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.